Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Obstet Gynaecol ; 39(4): 480-484, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30620232

RESUMEN

The objective of the present study was to investigate the frequency and the risk factors for restless legs syndrome (RLS) during pregnancy in an Italian population rarely studied, in epidemiological studies on the syndrome. A total of 648 women (median age: 35 years; interquartile range: 32-38), who delivered on randomly selected days at the obstetric department of our hospital, were identified. One hundred and thirty-two women (20.4%, 95% confidence interval (CI): 17.3-23.5) met the criteria for a diagnosis of RLS. The odds ratio (OR) of RLS was, in comparison with women aged <35 years, 1.69 (95% CI 1.14-2.51) in women aged ≥35 years. Subjective insufficient sleep (OR: 2.35, 95% CI 1.27-4.35) and difficulty in initiating sleep (OR: 1.73, 95% CI 1.15-2.63) increased the risk of RLS. This study confirms the high frequency of RLS in pregnant women. The risk of the condition was increased in women aged ≥35 years and in the women reporting sleep-wake disturbances during pregnancy. Impact statement What is already known on this subject? Restless legs syndrome (RLS), a common neurological, sensorimotor disorder, is two/three times more frequent in pregnant women than in the general population. The prevalence of RLS during pregnancy ranges widely, showing differences among populations. What do the results of this study add? This study adds data about the frequency and the risk factors for RLS during pregnancy in a Northern Italian population, rarely considered in epidemiological studies on the syndrome. Older age and sleep-wake disturbances are the main factors associated with the condition. What are the implications of these findings for clinical practice and/or further research? Screening for RLS might be useful for pregnant women to manage the condition. Further research is needed to investigate and define the potential impact of RLS during pregnancy on foetal and maternal health.


Asunto(s)
Complicaciones del Embarazo/epidemiología , Síndrome de las Piernas Inquietas/epidemiología , Trastornos del Sueño-Vigilia/epidemiología , Adulto , Femenino , Humanos , Italia/epidemiología , Oportunidad Relativa , Embarazo , Complicaciones del Embarazo/etiología , Prevalencia , Síndrome de las Piernas Inquietas/etiología , Factores de Riesgo , Trastornos del Sueño-Vigilia/complicaciones , Adulto Joven
2.
Magnes Res ; 30(1): 1-7, 2017 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-28392498

RESUMEN

A growing amount of evidence suggests that magnesium deficiency may play an important role in several clinical conditions concerning women health such as premenstrual syndrome, dysmenorrhea, and postmenopausal symptoms. A number of studies highlighted a positive correlation between magnesium administration and relief or prevention of these symptoms, thus suggesting that magnesium supplementation may represent a viable treatment for these conditions. Despite this amount of evidence describing the efficacy of magnesium, few and un-systematize data are available about the pharmacological mechanism of this ion for these conditions. Herein, we review and systematize the available evidence about the use of oral magnesium supplementation in several gynecological conditions and discuss the pharmacological mechanisms that characterize these interventions. The picture that emerges indicates that magnesium supplementation is effective in the prevention of dysmenorrhea, premenstrual syndrome, and menstrual migraine and in the prevention of climacteric symptoms.


Asunto(s)
Dismenorrea/tratamiento farmacológico , Magnesio/uso terapéutico , Osteoporosis Posmenopáusica/tratamiento farmacológico , Posmenopausia/efectos de los fármacos , Síndrome Premenstrual/tratamiento farmacológico , Suplementos Dietéticos , Dismenorrea/metabolismo , Femenino , Humanos , Magnesio/administración & dosificación , Posmenopausia/metabolismo , Síndrome Premenstrual/metabolismo
3.
Gynecol Oncol ; 139(3): 471-5, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26499935

RESUMEN

OBJECTIVE. The aim of this study was to evaluate the efficacy of fat grafting in the treatment of severe vulvar lichen sclerosus (LS). Our primary outcome was to assess the improvement of mucocutaneous trophism, the resolution/reduction of symptoms, and the histological features of the vulvar skin after treatment. The secondary outcome was to evaluate the improvement in life quality, and in resumption and quality of sexual life. METHODS. Between 2011 and 2014, 36 patients were offered fat grafting to treat LS. Inclusion criteria were age between 25 and 80 years, histopathologic diagnosis of LS, good health, failure of previous first line treatments. RESULTS. 34 out of 36 patients (94%) showed a better vulvar trophismof the skin and mucosae; 27 (75%) had an improvement in caliber and elasticity of the vaginal introitus; clitoris burying degree was reduced in 18 patients (50%), 30 (83%) reported an increased volume of labia major a and minor a, 34 (94%) had a complete disappearance of scratching lesions, and 28 (78%) showed a remission of white lesions. Eventually 34 patients (95%) stopped using topical corticosteroids routinely. The improvement in life quality was significant for both DLQI (p b 0001) and FSFI (p b 0001). CONCLUSIONS. Fat grafting may have a role as a support and completion treatment in selected cases of women with vulvar LS who do not respond to first line therapy or in severe cases where the anatomical impairment does not allow a regular sexual function and a good quality of life.


Asunto(s)
Tejido Adiposo/trasplante , Regeneración , Vulva/fisiología , Liquen Escleroso Vulvar/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Clítoris/fisiología , Elasticidad/fisiología , Femenino , Humanos , Persona de Mediana Edad , Membrana Mucosa/patología , Membrana Mucosa/fisiología , Calidad de Vida , Sexualidad , Piel/patología , Fenómenos Fisiológicos de la Piel , Liquen Escleroso Vulvar/patología , Liquen Escleroso Vulvar/fisiopatología
4.
J Pediatr Adolesc Gynecol ; 28(6): 462-70, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26233290

RESUMEN

STUDY OBJECTIVE: To investigate the rate of urinary incontinence (UI) in a sample of young nulligravid women and its potential risk factors and consequences on life habits. DESIGN AND PARTICIPANTS: The study is based on an online self-administered questionnaire taken by nulligravid women aged 15 to 25 years. MEASUREMENTS: The Questionnaire for Urinary Incontinence Diagnosis and part of The King's Health Questionnaire. Demographics and general characteristics are also recorded. RESULTS: We collected 1936 questionnaires (mean age of participants, 21 years); 12.4% of the sample reported any UI (95% confidence interval [CI] 10.9% to 13.9%). The estimated incidence of UI subtypes was 7.2% (95% CI 6.0% to 8.4%) stress UI, 3.4% (95% CI 2.6% to 4.3%) urge UI, and 1.9% (95% CI 1.3% to 2.6%) mixed UI. Age younger than 19 years and body mass index of 30 kg/m(2) or greater were associated in the multivariate analysis with an increased risk of UI. A self-reported history of psychological disorders increased the risk of UI (adjusted odds ratio [AOR] 1.4 and 95% CI 1.1% to 1.9%), without significant differences among the UI subtypes. A current history of constipation (AOR 1.9 and 95% CI 1.3% to 2.6%) and enuresis after the age of 5 also increased the risk of UI (AOR 2.9 and 95% CI 2.0% to 4.3%). CONCLUSION: In a sample of young nulligravid women, UI was not associated with any chronic risk factor known for elder age, but a prevention program may be proposed to women because of their young age (eg, educational session to promote the proper functioning of the pelvic floor). More detailed analyses are needed to better assess the prevalence of UI and risk factors in young nulligravid women.


Asunto(s)
Incontinencia Urinaria/epidemiología , Incontinencia Urinaria/etiología , Adolescente , Adulto , Índice de Masa Corporal , Estreñimiento/complicaciones , Enuresis/complicaciones , Femenino , Humanos , Incidencia , Trastornos Mentales/complicaciones , Análisis Multivariante , Oportunidad Relativa , Paridad , Factores de Riesgo , Encuestas y Cuestionarios , Adulto Joven
5.
Nutr Cancer ; 67(4): 569-79, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25826470

RESUMEN

Some studies have considered the association between diet and uterine fibroid risk, but the issue is largely unsettled. To identify potential modifiable risk factors for fibroid development, we have herein systematically reviewed prior publications dealing with this aspect. Comprehensive searches in electronic databases were conducted to collect studies published on association between uterine leiomyomas and both nutrients and food groups. We identified 13 publications deriving from 4 case-control, 3 cross-sectional, and 4 cohort studies. A protective effect has been demonstrated for consumption of fruits and green vegetables in both case-control and cohort studies. Moreover, very recent cross-sectional and case-control studies evaluating serum levels of 25-hydroxyvitamin-D3 tend to indicate that vitamin D insufficiency, which may in part be due to the diet intake, may play an important role in the development of uterine fibroids. No association was found with the intake of fibers, vitamin C and E, phytoestrogens and carotenoids, whereas association was controversial for the consumption of meat, fish, dairy products, and vitamin A. Most data have also been discussed herein in light of the available experimental and animal model results. These findings may be useful in devising nutritional strategies to reduce leiomyoma risk in humans.


Asunto(s)
Dieta , Leiomioma/epidemiología , Animales , Ácido Ascórbico/administración & dosificación , Carotenoides/administración & dosificación , Productos Lácteos , Grasas de la Dieta/administración & dosificación , Fibras de la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Ácido Fólico/administración & dosificación , Frutas , Humanos , Carne , Fitoestrógenos/administración & dosificación , Factores de Riesgo , Alimentos Marinos , Alimentos de Soja , Verduras , Vitamina A/administración & dosificación , Vitamina D/administración & dosificación , Vitamina E/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA